Sarepta Therapeutics, Inc. (SRPT) Strategic Restructure and ELEVIDYS Label Update Call Transcript

Core Insights - Sarepta Therapeutics is conducting a conference call to discuss its strategic restructure and updates regarding the ELEVIDYS label [2][3] Company Overview - Douglas S. Ingram, the CEO, is leading the discussion and will provide insights into the company's future direction and developments [3]